中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
19期
3017-3022
,共6页
干细胞%移植%骨髓间充质干细胞%心肌梗死%心肌细胞%肝细胞生长因子%胰岛素样生长因子
榦細胞%移植%骨髓間充質榦細胞%心肌梗死%心肌細胞%肝細胞生長因子%胰島素樣生長因子
간세포%이식%골수간충질간세포%심기경사%심기세포%간세포생장인자%이도소양생장인자
stem cels%bone marrow%mesenchymal stem cels%myocardial infarction%myocytes,cardiac%hepatocyte growth factor
背景:生长因子是干细胞强有力的动员剂,可以增加注射细胞的黏附力和增殖力,诱导干细胞向梗死区迁移、增殖分化,参与心肌修复。<br> 目的:观察肝细胞生长因子和胰岛素样生长因子的联合应用在骨髓间充质干细胞自体移植治疗心肌梗死中的作用。<br> 方法:分离培养兔骨髓间充质干细胞,原代培养后采用红光荧光染料 CM-Dil 标记。结扎冠脉前降支制作兔急性心肌梗死模型,然后随机均分为对照组、骨髓间充质干细胞组、肝细胞生长因子+胰岛素样生长因子组和肝细胞生长因子+胰岛素样生长因子+骨髓间充质干细胞组。于心肌梗死区心肌内分4点共注射不同干预试剂。Masson三色法染色检测存活心肌;免疫荧光检测骨髓间充质干细胞分化;心脏超声评价心功能。<br> 结果与结论:建模后4周,肝细胞生长因子+胰岛素样生长因子+骨髓间充质干细胞组 CM-Dil/cTNT+细胞数量明显多于骨髓间充质干细胞组,其存活心肌最多,左室射血分数改善最明显,左室舒张末径最小。肝细胞生长因子和胰岛素样生长因子联合应用促进自体移植的骨髓间充质干细胞向心肌细胞分化,增加存活心肌数量,改善心功能,抑制心室重构,可能成为心肌梗死后细胞治疗的有效方法。
揹景:生長因子是榦細胞彊有力的動員劑,可以增加註射細胞的黏附力和增殖力,誘導榦細胞嚮梗死區遷移、增殖分化,參與心肌脩複。<br> 目的:觀察肝細胞生長因子和胰島素樣生長因子的聯閤應用在骨髓間充質榦細胞自體移植治療心肌梗死中的作用。<br> 方法:分離培養兔骨髓間充質榦細胞,原代培養後採用紅光熒光染料 CM-Dil 標記。結扎冠脈前降支製作兔急性心肌梗死模型,然後隨機均分為對照組、骨髓間充質榦細胞組、肝細胞生長因子+胰島素樣生長因子組和肝細胞生長因子+胰島素樣生長因子+骨髓間充質榦細胞組。于心肌梗死區心肌內分4點共註射不同榦預試劑。Masson三色法染色檢測存活心肌;免疫熒光檢測骨髓間充質榦細胞分化;心髒超聲評價心功能。<br> 結果與結論:建模後4週,肝細胞生長因子+胰島素樣生長因子+骨髓間充質榦細胞組 CM-Dil/cTNT+細胞數量明顯多于骨髓間充質榦細胞組,其存活心肌最多,左室射血分數改善最明顯,左室舒張末徑最小。肝細胞生長因子和胰島素樣生長因子聯閤應用促進自體移植的骨髓間充質榦細胞嚮心肌細胞分化,增加存活心肌數量,改善心功能,抑製心室重構,可能成為心肌梗死後細胞治療的有效方法。
배경:생장인자시간세포강유력적동원제,가이증가주사세포적점부력화증식력,유도간세포향경사구천이、증식분화,삼여심기수복。<br> 목적:관찰간세포생장인자화이도소양생장인자적연합응용재골수간충질간세포자체이식치료심기경사중적작용。<br> 방법:분리배양토골수간충질간세포,원대배양후채용홍광형광염료 CM-Dil 표기。결찰관맥전강지제작토급성심기경사모형,연후수궤균분위대조조、골수간충질간세포조、간세포생장인자+이도소양생장인자조화간세포생장인자+이도소양생장인자+골수간충질간세포조。우심기경사구심기내분4점공주사불동간예시제。Masson삼색법염색검측존활심기;면역형광검측골수간충질간세포분화;심장초성평개심공능。<br> 결과여결론:건모후4주,간세포생장인자+이도소양생장인자+골수간충질간세포조 CM-Dil/cTNT+세포수량명현다우골수간충질간세포조,기존활심기최다,좌실사혈분수개선최명현,좌실서장말경최소。간세포생장인자화이도소양생장인자연합응용촉진자체이식적골수간충질간세포향심기세포분화,증가존활심기수량,개선심공능,억제심실중구,가능성위심기경사후세포치료적유효방법。
BACKGROUND:The growth factor is a potent mobilization agent for stem cels, which can increase adhesion and proliferation of injected cels, induce stem cels to migrate to the infarct zone, proliferate, differentiate, as wel as participate in myocardiac repair. <br> OBJECTIVE: To investigate the effect of hepatocyte growth factor (HGF) and insulin-like growth factor (IGF) on transplantation of bone marrow mesenchymal stem cels (BMSCs) after acute myocardial infarction. <br> METHODS: Primary rabbit BMSCs were culturedin vitro and labeled by red fluorescence dye CM-Dil for transplantation. After the mid third of left anterior descending was ligated, model rabbits were grouped into four groups: control group, BMSCs group, HGF+IGF group, and HGF+IGF+BMSCs group (n=6 in each group). Different interventional agents were injected into the myocardium at four sites within the ischemic region. Masson trichrome staining was performed to determine viable myocardium, and immunofluorescence staining was used to identify BMSCs differentiation. The cardiac function was assessed with Doppler echocardiography. <br> RESULTS AND CONCLUSION:Four weeks after treatment, CM-Dil/cTNT+ cels significantly increased in the HGF+IGF+BMSCs group, compared with BMSCs group. Consequently, viable myocardial tissues significantly increased, left ventricular ejection fraction was significantly improved, and left ventricular end-diatolic volume significantly decreased in the HGF+IGF+BMSCs group, relative to the other three groups. Combination of HGF and IGF that promotes differentiation of transplanted autologous BMSCs into cardiomyocytes, thus increasing viable myocardium, improving left ventricular function, and inhibiting left ventricular remodeling, may be a new method for the celltreatment of acute myocardial infarction.